Publicacións en colaboración con investigadores/as de University of Leipzig (11)

2022

  1. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

    Leukemia, Vol. 36, Núm. 1, pp. 90-99

2021

  1. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial

    Leukemia, Vol. 35, Núm. 9, pp. 2539-2551

2020

  1. Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

    Blood, Vol. 135, Núm. 5, pp. 371-380

  2. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: A subanalysis from the RATIFY trial

    Blood Advances, Vol. 4, Núm. 19, pp. 4945-4954

2017

  1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Blood, Vol. 129, Núm. 4, pp. 424-447

  2. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 Mutation

    New England Journal of Medicine, Vol. 377, Núm. 5, pp. 454-464

2010

  1. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet

    Blood, Vol. 115, Núm. 3, pp. 453-474

2006

  1. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome

    Bone Marrow Transplantation, Vol. 37, Núm. 2, pp. 183-189

2005

  1. Stem cell transplantation from identical twins in patients with myelodysplastic syndromes

    Bone Marrow Transplantation, Vol. 35, Núm. 1, pp. 37-43

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051

2002

  1. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

    Blood, Vol. 100, Núm. 12, pp. 3877-3886